Ramy Farid - 02 Feb 2023 Form 3 Insider Report for Structure Therapeutics Inc. (GPCR)

Role: Director
Signature: Jun Yoon, Attorney-in-Fact
Issuer symbol: GPCR
Transactions as of: 02 Feb 2023
Net transactions value: $0
Form type: 3
Filing time: 02 Feb 2023, 17:24:56 UTC
Previous filing: 05 Jan 2023
Next filing: 09 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	GPCR	Ordinary Shares						2,618,250	02 Feb 2023	By Schrodinger, Inc.	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	GPCR	Series B Preferred Shares							02 Feb 2023	Ordinary Shares	642,245		By Schrodinger, Inc.	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person is President, Chief Executive Officer and a member of the board of directors of Schrodinger, Inc. ("Schrodinger") and may be deemed to share voting and dispositive power over the shares held by Schrodinger. The Reporting Person disclaims beneficial ownership of the shares held by Schrodinger.
F2	All outstanding Preferred Shares will automatically convert into Ordinary Shares immediately upon the closing of Issuer's initial public offering, for no additional consideration at a rate of one Ordinary Share for each one Preferred Share, based on the conversion price currently in effect. The Preferred Shares have no expiration date.